Canada Markets closed

Codexis, Inc. (CDXS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1400+0.2000 (+5.08%)
At close: 04:00PM EDT
4.1600 +0.02 (+0.48%)
After hours: 07:43PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close3.9400
Bid4.0500 x 2900
Ask4.1600 x 1200
Day's Range3.9200 - 4.1500
52 Week Range3.7900 - 22.2200
Avg. Volume638,366
Market Cap271.944M
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-0.4040
Earnings DateMay 03, 2023 - May 08, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.25
  • Simply Wall St.

    Codexis, Inc.'s (NASDAQ:CDXS) Intrinsic Value Is Potentially 24% Below Its Share Price

    Key Insights The projected fair value for Codexis is US$2.93 based on 2 Stage Free Cash Flow to Equity Codexis' US$3.88...

  • GlobeNewswire

    Codexis Announces New Employment Inducement Grants

    REDWOOD CITY, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to two new employees as approved by the Compensation Committee of Codexis’s Board of Directors. The newly hired employees received equity awards consisting of an aggregate of (i) options to purchase 43,403 shares of Codexis’ common stock and (ii) restricted stock units (RSUs) for 9,723 shares of Codexis common stock as induceme

  • GlobeNewswire

    Codexis to Participate in Cowen 43rd Annual Health Care Conference

    REDWOOD CITY, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading enzyme engineering company, today announced that management will participate in both a panel discussion and a fireside chat at the Cowen 43rd Annual Health Care Conference, being held March 6-8, 2023, in Boston, Massachusetts. Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Codexis, will participate in a panel discussion titled, “SynBio & AI Driven Drug Discovery,” taking place on Mo